ASHLAND INC.

ASH

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
ASH
CIK0001674862
SIC5160
SectorWholesale Trade
Industry CategoryWholesale
Industry GroupWholesale – Chemicals & Allied Products

Contact

Address8145 BLAZER DRIVE, WILMINGTON, DE, 19808
Website ashland.com
Phone304-995-3000
CEOGuillermo Novo
Employees3,900

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1.82 billion
Pre-Tax Income$-809.00 million
Net Income$-845.00 million
Net Income to Common$-845.00 million
EPS$-18.23
View All
Balance Sheet
Cash$215.00 million
Assets$4.61 billion
Liabilities$2.71 billion
Common Equity$1.90 billion
Liabilities & Equity$4.61 billion
View All
Cash Flow Statement
Calculations
NOPAT$-542.50 million
EBITDA$-532.00 million
Price to EarningsN/A
Price to Book$1.42
ROE-35.41%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Ashland’s (ASH) New 5.7% Backer: Endorsement Of Its Specialty Focus Or Just Opportunistic Timing?

Ashland recently saw its outlook re-rated after a major investment firm disclosed a 5.7% stake in the company, following a quarter in which earnings and sales declined due to portfolio optimization and divestitures of lower-margin products. This combination of portfolio reshaping and fresh institutional interest highlights a tension between short-term financial pressure and renewed confidence in Ashland’s longer-term specialty chemicals focus. We’ll now examine how the major investor’s 5.7%...

Article Link

Assessing Ashland’s Valuation After a Major New Stake and Fresh Analyst Optimism

Ashland (ASH) just drew fresh attention after a prominent investment firm disclosed a 5.7% stake, a clear signal it sees long term potential even as the company works through recent earnings hiccups. See our latest analysis for Ashland. The fresh 5.7% stake and Ashland’s longer term portfolio cleanup seem to have jolted sentiment, with a roughly 17% 1 month share price return standing in sharp contrast to its negative 1 year total shareholder return and signaling momentum may be turning. If...

Article Link

Ashland, Bitdeer, and More Stocks See Action From Activist Investors

Activists also report to the SEC on Dianthus Therapeutics, Centessa Pharmaceuticals, and Insight Enterprises.

Article Link

Ashland (ASH) Up 14.9% Since Last Earnings Report: Can It Continue?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Article Link

Implied Volatility Surging for Ashland Stock Options

Investors need to pay close attention to Ashland stock based on the movements in the options market lately.

Article Link